drugset / Trial / NCT01533077

Pharmacokinetic Interaction Between BIA 9-1067 and Standard-release Levodopa/Carbidopa

NCT01533077

Phase 1 Completed 18 enrolled Bial - Portela C S.A.
RandomizedCrossoverOpen-labelTreatment

Summary

To investigate the pharmacokinetics of levodopa when administered concomitantly with BIA 9-1067 or 1 hour after.

Timeline

Start
2009-03
Primary completion
2009-10
Completion
2010-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Levodopa Small molecule 25 mg
Subject Levodopa Small molecule 100 mg
Subject Opicapone Small molecule 50 mg

Indications